18F-MNI-654
N/A
Report date: 2022/01/17 12:14:22
NME
Base Information
Drug Name18F-MNI-654
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[4]
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesInst For Neurodegenerative Disorders
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A